FDA Clears Abbott’s AI-Powered Coronary Imaging Software
The Ultreon 3.0 software uses optical coherence tomography and artificial intelligence to guide physicians during procedures to open blocked arteries.
The Ultreon 3.0 software uses optical coherence tomography and artificial intelligence to guide physicians during procedures to open blocked arteries.
The AI-enabled software automates whole-body tumor burden analysis for PSMA PET/CT and SPECT/CT studies to help clinicians assess treatment eligibility and monitor response.
Direct integration with the operating system is designed to give health systems a single environment for managing regulatory-cleared AI tools within existing imaging workflows.
The Ultreon 3.0 software uses optical coherence tomography and artificial intelligence to guide physicians during procedures to open blocked arteries.
The new cloud-first platform will use predictive analytics to help manage patient flow, staffing, and equipment.
Read MoreThe latest Image Suite V4 release introduces AI-generated companion images, enhanced visualization tools, and workflow upgrades to support more confident diagnoses and a better user experience.
Read MoreThe cloud-native solution aims to enable providers to easily access patient health history, streamline operations, and personalize treatment.
Read MoreTo address rising vulnerabilities from third-party software, the Indiana-based network will implement a real-time risk management solution.
Read MoreThe designation will expedite the review process for the CT-based artificial intelligence, which flags numerous acute conditions simultaneously.
Read MoreThe updated platform is designed to shorten the time between cancer diagnosis and treatment by streamlining clinical workflows.
Read More
The research suggests AI may help identify more aggressive breast cancers and perform comparably to experts in breast cancer screening.